Fulminant liver failure in a child with invasive group A streptococcal infection

European Journal of Pediatrics

Volumn 162, Issue 4, 2003, Pages 245-247

  Biesel Desthieux, M N ^a   Tissieres P ^a   Belli, D C ^a   Le Coultre, C ^a   Gervaix, A ^a   Masserey Spicher, V ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Child; Fulminant liver failure; Group A streptococcus; Invasive infection; Streptococcal pyrogenic exotoxin

Indexed keywords

TOXIC SHOCK SYNDROME TOXIN 1;

ARTICLE; BACTEREMIA; BACTERIAL INFECTION; CASE REPORT; CHILD; HUMAN; INFECTION RISK; LIVER FAILURE; LIVER TRANSPLANTATION; MALE; NECROTIZING FASCIITIS; PREVALENCE; PRIORITY JOURNAL; SCARLET FEVER; STRAIN DIFFERENCE; STREPTOCOCCUS GROUP A; TISSUE INJURY; TOXIC SHOCK SYNDROME;

EID: 0037387798     PISSN: 03406199     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00431-002-1137-z     Document Type: Article

References (16)

1. Alonso EM, Sokol RJ, Hart J, Tyson RW, Michael R, Narkewicz MR, Witington PF (1995) Fulminant hepatitis associated with centrilobular hepatic necrosis in young children. J Pediatr 127: 888-894
2. American Academy of Pediatrics: Committee on Infectious Diseases (1998) Severe invasive group A streptococcal infections: a subject review. Pediatrics 101: 136-140
3. Demers B, Simor AE, Vellend H, Schlievert PM, Byrne S, Jamieson F, Walmsley S, Low DE (1993) Severe invasive group A streptococcal infections in Ontario, Canada: 1987-1991. Clin Infect Dis 16: 792-800
4. Eriksson BK, Andersson J, Holm SE, Norgren M (1998) Epidemiology and clinical aspects of invasive group A streptococcal infections and the streptococcal toxic shock syndrome. Clin Infect Dis 27: 1428-1436
5. Girisch M, Heininger U (2000) Scarlet fever associated with hepatitis A report of two cases. Infection 28: 251-253
6. Kocak N, Ozsoylu S, Ertugrul M, Ozdol G (1976) Liver damage in scarlet fever. Clin Pediatr 15: 462-464
7. MacMahon HE, Mallory FB (1931) Streptococcus hepatitis. Am J Pathol 7: 299-325
8. Mascini EM, Jansze M, Schellekens JFP, Musser JM, Faber JAJ, Verhoef-Verhage LAE, Schouls L, Van Leeuwen WJ, Verhoef J, Van Dijk H (2000) Invasive group A streptococcal disease in the Netherlands: evidence for a protective role of anti-toxin A antibodies. J Infect Dis 181: 631-638
9. nd ed. Lippincott Williams & Wilkins, Philadelphia, pp 845-867
10. Peltekian KM, Levy GA (1997) Role of cytokines and immune mechanisms in acute liver failure. In: Lee WM, Williams R, eds. Acute liver failure. Cambridge University Press, Cambridge, pp 67-78
11. Price VF, Miller MG, Jollow DJ (1987) Mechanisms of fasting-induced potentialisation of acetaminophen hepatotoxicity in the rat. Biochem Pharmacol 36: 427-433
12. Robbens E, De Man M, Schurgers M, Boelaert J, Lameire N (1986) Systemic complications of streptococcal scarlet fever: two case reports and a review of the literature. Acta Clin Belg 41: 311-318
13. Rolando N, Gimson A, Wade J, Philpott-Howard J, Casewell M, Williams R (1993) Prospective controlled trial of selective parenteral and enteral antimicrobial regimen in fulminant hepatic failure. Hepatology 17: 196-201
14. Rolando N, Wade J, Davalos M, Wendon J, Philipott-Howard J, Williams R (2000) The systemic inflammatory response syndrome in acute liver failure. Hepatology 32: 734-739
15. Sheron N, Keane H, Goka J, Alexander G, Williams R, Wendon J (2001) Circulating acute phase cytokines and cytokine inhibitors in fulminant hepatic failure: associations with mortality and haemodynamics. Clin Intensive Care 12: 127-134
16. Stevens DL (2001) Invasive streptococcal infections. J Infect Chemother 7: 69-80